COMPANY PROFILE

Claret Medical

Claret Medical develops cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI) and other procedures

Santa Rosa, United StatesFounded 2009Biotech & Life Sciences

Valuation $250–500M Last recorded · 2018

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Claret Medical

Claret Medical specializes in developing advanced cerebral protection systems designed to safeguard patients during cardiovascular procedures. Operating in the medical device industry, Claret Medical serves healthcare professionals and institutions focused on interventional cardiology. The company's core product, the Sentinel Cerebral Protection System, is engineered to capture and remove debris dislodged during heart valve procedures, thereby reducing the risk of stroke. Claret Medical generates revenue through the sale of its proprietary medical devices and ongoing support services. The company targets hospitals, clinics, and specialized cardiovascular centers, aiming to improve patient outcomes and procedural safety.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2009
Headquarters: Santa Rosa, United States
Open positions: None listed
Dealroom signal: 24.7/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Risk Management, Biotechnology, Cardiology and cardiovascular, Neurology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology: Hardware
Client focus: b2c
Links: Website

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

9 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Jul 2018	$270M	$270M	Boston Scientific	—
SERIES C✓Equity / VC	Oct 2017	$15M	$58M	HealthCor Partners · Incept · Easton Capital Investment Group · Sante Ventures	—

Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Claret Medical website traffic

Latest recorded traffic for Claret Medical is 320 monthly website visits.

Latest monthly visits320

Monthly website visitsApr 2016–Jun 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CPCoLucid PharmaceuticalsDeveloping oral lasmiditan for the treatment of migraine headache and intravenous lasmiditan for treatment of headache pain by health care professionals	Cambridge, United States	Acquired	2	$95M	$960M
SPSpecialtyCareSpecialtyCare provides outsourced clinical services for hospitals, physicians, and clinicians in the United States.	Nashville, United States	Operational
BTBioSig TechnologiesBioSig Technologies \| Improving the Quality of Cardiac Recordings	Westport, United States	Operational
PHPhotPharmicsPhotoPharmics: Advances in Parkinson's Therapy	Highland, United States	Operational
IOioveraMyoScience develops and commercializes technology-driven dermatological products	Fremont, United States	Acquired
ABArkis BioSciencesMedical device company providing minimally invasive surgical instrumentation and advanced implantable technology	Knoxville, United States	Acquired
SMSadra MedicalFocused on developing minimal invasive alternatives to surgical valve replacement and improve patient care	Campbell, United States	Acquired
SASecond Heart AssistSecond Heart is developing a minimally invasive circulatory support platform based on proprietary aortic stent pump technology	Santa Monica, United States	Operational